MaxCyte, Inc. (MXCT)
USD 2.6
(-5.8%)
USD 2.6
(-5.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -44.12 Million USD | -112.3% |
| 2022 | -20.87 Million USD | -24.87% |
| 2021 | -16.76 Million USD | -67.09% |
| 2020 | -9.94 Million USD | 14.29% |
| 2019 | -11.6 Million USD | -46.64% |
| 2018 | -7.91 Million USD | 13.53% |
| 2017 | -9.14 Million USD | -251.61% |
| 2016 | -2.6 Million USD | -301.67% |
| 2015 | -647.8 Thousand USD | 45.27% |
| 2014 | -1.18 Million USD | -71.97% |
| 2013 | -688.3 Thousand USD | 62.0% |
| 2012 | -1.81 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -10.86 Million USD | 2.48% |
| 2024 Q1 | -11.13 Million USD | -59.62% |
| 2023 Q2 | -12.04 Million USD | 1.38% |
| 2023 Q3 | -12.87 Million USD | -6.84% |
| 2023 Q1 | -12.21 Million USD | -214.92% |
| 2023 Q4 | -6.97 Million USD | 45.81% |
| 2023 FY | - USD | -112.3% |
| 2022 Q4 | -3.87 Million USD | 30.83% |
| 2022 Q3 | -5.6 Million USD | 27.29% |
| 2022 Q2 | -7.71 Million USD | -115.44% |
| 2022 FY | - USD | -24.87% |
| 2022 Q1 | -3.57 Million USD | 19.24% |
| 2021 Q4 | -4.43 Million USD | -118.85% |
| 2021 FY | - USD | -67.09% |
| 2021 Q2 | -4.08 Million USD | 32.48% |
| 2021 Q3 | -2.02 Million USD | 50.4% |
| 2021 Q1 | -6.04 Million USD | -189.09% |
| 2020 FY | - USD | 14.29% |
| 2020 Q3 | -2.54 Million USD | 10.36% |
| 2020 Q4 | -2.09 Million USD | 17.81% |
| 2020 Q2 | -2.83 Million USD | -2.63% |
| 2020 Q1 | -2.76 Million USD | -78.24% |
| 2019 Q4 | -1.55 Million USD | 0.0% |
| 2019 FY | - USD | -46.64% |
| 2019 Q3 | -1.55 Million USD | 64.33% |
| 2019 Q2 | -4.35 Million USD | 0.0% |
| 2019 Q1 | -4.35 Million USD | -131.35% |
| 2018 Q4 | -1.88 Million USD | 0.0% |
| 2018 FY | - USD | 13.53% |
| 2018 Q2 | -2.15 Million USD | 0.0% |
| 2018 Q3 | -1.88 Million USD | 12.92% |
| 2018 Q1 | -2.15 Million USD | 17.25% |
| 2017 Q1 | -1.96 Million USD | -129.34% |
| 2017 Q2 | -1.96 Million USD | 0.0% |
| 2017 Q4 | -2.6 Million USD | 0.0% |
| 2017 Q3 | -2.6 Million USD | -32.86% |
| 2017 FY | - USD | -251.61% |
| 2016 Q1 | -452.3 Thousand USD | -622.52% |
| 2016 FY | - USD | -301.67% |
| 2016 Q4 | -856.55 Thousand USD | 0.0% |
| 2016 Q3 | -856.55 Thousand USD | -89.38% |
| 2016 Q2 | -452.3 Thousand USD | 0.0% |
| 2015 Q3 | -62.6 Thousand USD | 76.93% |
| 2015 Q2 | -271.3 Thousand USD | 0.0% |
| 2015 Q1 | -271.3 Thousand USD | -76.57% |
| 2015 FY | - USD | 45.27% |
| 2015 Q4 | -62.6 Thousand USD | 0.0% |
| 2014 FY | - USD | -71.97% |
| 2014 Q4 | -153.65 Thousand USD | 0.0% |
| 2014 Q1 | -438.2 Thousand USD | 0.0% |
| 2014 Q2 | -438.2 Thousand USD | 0.0% |
| 2014 Q3 | -153.65 Thousand USD | 64.94% |
| 2013 FY | - USD | 62.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -227.189% |
| Cerus Corporation | -26.53 Million USD | -66.295% |
| OrthoPediatrics Corp. | -8.38 Million USD | -426.524% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -320.487% |
| Talis Biomedical Corporation | -66.04 Million USD | 33.185% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -164.636% |
| Inogen, Inc. | -45.67 Million USD | 3.395% |
| Spectral AI, Inc. | -12.26 Million USD | -259.876% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 7.475% |
| CVRx, Inc. | -38.73 Million USD | -13.935% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1150.794% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -264.483% |
| Orthofix Medical Inc. | -86.98 Million USD | 49.269% |
| Venus Concept Inc. | -26.11 Million USD | -68.989% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 11.338% |
| Bioventus Inc. | -23.07 Million USD | -91.279% |
| BrainsWay Ltd. | -2.31 Million USD | -1809.476% |
| Envoy Medical, Inc. | -18.23 Million USD | -141.956% |
| electroCore, Inc. | -17.76 Million USD | -148.468% |
| IceCure Medical Ltd | -15.25 Million USD | -189.307% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 11.302% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -161.799% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -275.366% |
| Nexalin Technology, Inc. | -5.69 Million USD | -675.258% |
| PAVmed Inc | -75.74 Million USD | 41.739% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 17.914% |
| RxSight, Inc. | -41.03 Million USD | -7.532% |
| Sight Sciences, Inc. | -49.41 Million USD | 10.699% |
| SI-BONE, Inc. | -34.44 Million USD | -28.108% |
| TELA Bio, Inc. | -40.63 Million USD | -8.601% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 24.306% |
| Treace Medical Concepts, Inc. | -39 Million USD | -13.126% |
| LivaNova PLC | 39.01 Million USD | 213.102% |
| 908 Devices Inc. | -34.02 Million USD | -29.693% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 60.098% |
| Nemaura Medical Inc. | -7.28 Million USD | -505.567% |
| NeuroPace, Inc. | -22.83 Million USD | -93.256% |
| LENSAR, Inc. | -8.71 Million USD | -406.403% |
| Apyx Medical Corporation | -18.11 Million USD | -143.64% |
| Cutera, Inc. | -136.56 Million USD | 67.686% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1205.562% |
| BioSig Technologies, Inc. | -28.15 Million USD | -56.755% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1853.895% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -110.243% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 111.505% |
| Axonics, Inc. | 7.77 Million USD | 667.563% |
| Outset Medical, Inc. | -153.78 Million USD | 71.306% |
| IRIDEX Corporation | -7.44 Million USD | -492.481% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 55.015% |
| IRadimed Corporation | 20.8 Million USD | 312.147% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -447.358% |
| INVO Bioscience, Inc. | -6.88 Million USD | -541.393% |
| Telesis Bio, Inc. | -40.49 Million USD | -8.977% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 220.315% |
| Varex Imaging Corporation | 67.2 Million USD | 165.667% |
| Quipt Home Medical Corp. | 44.07 Million USD | 200.129% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -305.961% |
| Pulmonx Corporation | -55.09 Million USD | 19.901% |
| Dynatronics Corporation | -976 Thousand USD | -4421.274% |
| Modular Medical, Inc. | -17.1 Million USD | -158.013% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -204.646% |
| Semler Scientific, Inc. | 23.58 Million USD | 287.07% |
| InMode Ltd. | 196.28 Million USD | 122.482% |
| Bruker Corporation | 599 Million USD | 107.367% |
| Cytosorbents Corporation | -28.81 Million USD | -53.165% |
| DexCom, Inc. | 916.7 Million USD | 104.814% |
| Align Technology, Inc. | 799.03 Million USD | 105.523% |
| Viveve Medical, Inc. | -20.61 Million USD | -114.037% |
| ZimVie Inc. | 91.07 Million USD | 148.453% |
| Movano Inc. | -29.12 Million USD | -51.512% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -901.089% |
| Nexalin Technology, Inc. | -5.69 Million USD | -675.258% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1150.794% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 77.33% |
| Profound Medical Corp. | -27.12 Million USD | -62.693% |
| Insulet Corporation | 323.6 Million USD | 113.637% |
| enVVeno Medical Corporation | -25.01 Million USD | -76.385% |
| Surmodics, Inc. | 1.18 Million USD | 3814.478% |
| iCAD, Inc. | -6.56 Million USD | -572.171% |
| Nuwellis, Inc. | -16.35 Million USD | -169.797% |
| Biotricity, Inc. | -8.82 Million USD | -399.849% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 54.442% |
| Aethlon Medical, Inc. | -11.84 Million USD | -272.416% |
| InspireMD, Inc. | -20.91 Million USD | -111.028% |
| PAVmed Inc. | -75.74 Million USD | 41.739% |
| BIOLASE, Inc. | -15.13 Million USD | -191.486% |
| Beyond Air, Inc. | -59.03 Million USD | 25.246% |
| FONAR Corporation | 28.25 Million USD | 256.197% |
| AxoGen, Inc. | -13.32 Million USD | -231.092% |
| Vivani Medical, Inc. | -26.6 Million USD | -65.845% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 279.813% |
| Inari Medical, Inc. | 7.11 Million USD | 720.385% |
| UFP Technologies, Inc. | 72.74 Million USD | 160.663% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1203.331% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -616.83% |
| Tenon Medical, Inc. | -15.52 Million USD | -184.183% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -189.061% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -6.395% |
| AdaptHealth Corp. | -171.09 Million USD | 74.208% |
| Sintx Technologies, Inc. | -6.6 Million USD | -568.606% |
| NanoVibronix, Inc. | -3.43 Million USD | -1184.658% |
| Quanterix Corporation | -38.08 Million USD | -15.858% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -305.961% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 147193.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 84.086% |
| TransMedics Group, Inc. | -7.6 Million USD | -480.402% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -102.748% |
| NeuroMetrix, Inc. | -7.09 Million USD | -521.888% |
| Hyperfine, Inc. | -47.06 Million USD | 6.232% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 24.318% |
| Biomerica, Inc. | -5.99 Million USD | -636.326% |
| Bone Biologics Corporation | 479.57 Thousand USD | 9301.538% |
| AVITA Medical, Inc. | -39.56 Million USD | -11.525% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -381.068% |
| Silk Road Medical, Inc | -45.08 Million USD | 2.112% |